JX-594 (vaccine)
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Jennerex invents the JX-594. To put it bluntly, Jennerex Jennerex Biotherapeutics, is a private clinical-stage biotherapeutics company whose research focuses on the development and commercialization of targeted oncolytic immunotherapies. The vaccine JX-594 has as aim to treat solid tumors and severe cancers. Medical analysts have also states that JX-594 has proved to prevent the growth of new tumors and the development of malignancy. Various medical analysis and…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Jennerex invents the JX-594. To put it bluntly, Jennerex Jennerex Biotherapeutics, is a private clinical-stage biotherapeutics company whose research focuses on the development and commercialization of targeted oncolytic immunotherapies. The vaccine JX-594 has as aim to treat solid tumors and severe cancers. Medical analysts have also states that JX-594 has proved to prevent the growth of new tumors and the development of malignancy. Various medical analysis and experiments have demonstrated that JX-594 also referred to as the Pexa-Vec, is a treatment which requires small doses that can potentially reduced tumor size and decreasing blood flow to tumors. Moreover, Pexa-Vec is an oncolytic immunotherapy designed to rapidly de-bulktumors via tumor cell lysis; activate an antivascular effect with rapid tumor vascular knockout; induce a durable immuneresponseagainst tumors...